The Use of Hydroxychloroquine in Patients with Pemphigus Erythematosus.
- Author:
Seung Gu KANG
1
;
Chang Woo LEE
Author Information
1. Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Hydroxychloroquine;
Pemphigus erythematosus
- MeSH:
Adrenal Cortex Hormones;
Humans;
Hydroxychloroquine*;
Pemphigus*;
Sunlight
- From:Korean Journal of Dermatology
1996;34(6):980-983
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pemphigus erythematosus (PE) is a superficial type of pemphigus, which can be aggravated by sunlight (espicially UV light). Because of the known side effects of corticosteroids, we evaluated the efficacy of hydroxychloroquine as a corticosteroid-sparing agent and/or the effect of a single-drug regimen in two patients with PE with photosensitivity. We obtained a good therapeutic response with hydroxychloroquine in these two patients with PE. This drug could be used in selected patients with pemphigus who are prednisolone/ immunosuppressive-resistant or who have certain degrees of photosensitivity.
